Results of salvage stereotactic radiosurgery in 14 patients with grade III or IV gliomas;Résultats de l'irradiation en conditions stéré otaxiques de rattrapage de 14 patients atteints d'un gliome de grade III ou IV

Revue Neurologique

Volumn 160, Issue 5 I, 2004, Pages 539-545

  Noel G ^a,b   Ben Ammar, Chiraz N ^a   Feuvret, L ^a   Valery, C A ^a   Cornu, P ^a   Boisserie, G ^a   Simon, J M ^a   Hasboun, D ^a   Tep, B ^a   Delattre, J Y ^a   Sanson, M ^a   Baillet, F ^a   Mazeron, J J ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b Ctr de Protontherapie d'Orsay   (France)

Author keywords

Malignant brain tumor; Primary brain tumor; Radiosurgery; Relapse; Stereotactic radiotherapy

Indexed keywords

ADULT; ARTICLE; CANCER CONTROL; CANCER GRADING; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL PROTOCOL; FEMALE; FOLLOW UP; GLIOMA; HUMAN; MALE; PROGNOSIS; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION NECROSIS; RADIOSURGERY; SALVAGE THERAPY; STEREOTAXIC SURGERY; SURVIVAL RATE;

EID: 2942733528     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0035-3787(04)70983-2     Document Type: Article

References (34)

1. ALEXANDER E, III LOEFFLER JS. (1992). Radiosurgery using a modified linear accelerator. Neurosurg Clin N Am, 3: 167-190.
2. ARCICASA M, RONCADIN M, BIDOLI E, et al. (1999). Reirradiation and lomustine in patients with relapsed high-grade gliomas. Int J Radiat Oncol Biol Phys, 43: 789-793.
3. BAUMAN GS, SNEED PK, WARA WM et al. (1996). Reirradiation of primary CNS tumors. Int J Radiat Oncol Biol Phys, 36: 433-441.
4. BRANDES AA, FIORENTINO MV. (1996). The role of chemotherapy in recurrent malignant gliomas: an overview. Cancer Invest, 14: 551-559.
5. BREM H, PIANTADOSI S, BURGER PC et al. (1995). Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group. Lancet, 345: 1008-1012.
6. CHAMBERLAIN MC, BARBA D, KORMANIK P, SHEA WM. (1994). Stereotactic radiosurgery for recurrent gliomas. Cancer, 74: 1342-1347.
7. CHINOT OL, HONORE S, DUFOUR H et al. (2001). Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy. J Clin Oncol, 19: 2449-2455.
8. CHO KH, HALL WA, GERBI BJ, et al. (1999). Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas. Int J Radiat Oncol Biol Phys, 45: 1133-1141.
9. DE CREVOISIER R, PIERGA JY, DENDALE R et al. (1997). Radiotherapy of glioblastoma. Cancer Radiother, 1: 194-207.
10. DIRKS P, BERNSTEIN M, MULLER PJ, TUCKER WS. (1993). The value of reoperation for recurrent glioblastoma. Can J Surg, 36: 271-275.
11. FEUVRET L, GERMAIN I, CORNU P et al. (1998). Importance of radiotherapy in stereotactic conditions (radiosurgery) in brain metastasis: experience and results of the Hopital Pitie-Salpetriere Group. Cancer Radiother, 2: 272-281.
12. FEUVRET L, GERMAIN I, CORNU P et al. (1999). First treatment for brain metastases by stereotactic radiosurgery. Bull Cancer, 86: 666-672.
13. GARDEN AS, MAOR MH, YUNG WK et al. (1991). Outcome and patterns of failure following limited-volume irradiation for malignant astrocytomas. Radiother Oncol, 20: 99-110.
14. GASPAR LE, FISHER BJ, MACDONALD DR et al. (1992). Supratentorial malignant glioma: patterns of recurrence and implications for external beam local treatment. Int J Radiat Oncol Biol Phys, 24: 55-57.
15. GLASS J, SILVERMAN CL, AXELROD R, et al. (1997). Fractionated stereotactic radiotherapy with cis-platinum radiosensitization in the treatment of recurrent, progressive, or persistent malignant astrocytoma. Am J Clin Oncol, 20: 226-229.
16. HALL WA, DJALILIAN HR, SPERDUTO PW et al. (1995). Stereotactic radiosurgery for recurrent malignant gliomas. J Clin Oncol, 13: 1642-1648.
17. HARSH GR, LEVIN VA, GUTIN PH, et al. (1987). Reoperation for recurrent glioblastoma and anaplastic astrocytoma. Neurosurgery, 21: 615-621.
18. HOCHBERG FH, PRUITT A. (1980). Assumptions in the radiotherapy of glioblastoma. Neurology, 30: 907-911.
19. HUDES RS, CORN BW, WERNER-WASIK M et al. (1999). A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma. Int J Radiat Oncol Biol Phys, 43: 293-298.
20. KRETH FW, WARNKE PC, SCHEREMET R, OSTERTAG CB. (1993). Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg, 78: 762-766.
21. LARSON DA, GUTIN PH, MCDERMOTT M et al. (1996). Gamma knife for glioma: selection factors and survival. Int J Radiat Oncol Biol Phys, 36:1045-1053.
22. LEDERMAN G, ARBIT E, ODAIMI M, et al. (1998). Fractionated stereotactic radiosurgery and concurrent taxol in recurrent glioblastoma multiforme: a preliminary report. Int J Radiat Oncol Biol Phys, 40: 661-666.
23. LEIBEL SA, GUTIN PH, WARA WM et al. (1989). Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys, 17: 1129-1139.
24. NAKAGAWA K, AOKI Y, FUJIMAKI T et al. (1998). High-dose conformal radiotherapy influenced the pattern of failure but did not improve survival in glioblastoma multiforme. Int J Radiat Oncol Biol Phys, 40: 1141-1149.
25. NEDZI LA, KOOY H, ALEXANDER E III et al. (1991). Variables associated with the development of complications from radiosurgery of intracranial tumors. Int J Radiat Oncol Biol Phys, 21: 591-599.
26. NOEL G, PROUDHOM MA, VALERY CA et al. (2001). Radiosurgery for re-irradiation of brain metastasis: results in 54 patients. Radiother Oncol, 60: 61-67.
27. RAJAN B, ROSS G, LIM CC et al. (1994). Survival in patients with recurrent glioma as a measure of treatment efficacy: prognostic factors following nitrosourea chemotherapy. Eur J Cancer, 30A: 1809-1815.
28. SHEPHERD SF, LAING RW, COSGROVE VP et al. (1997). Hypofractionated stereotactic radiotherapy in the management of recurrent glioma. Int J Radiat Oncol Biol Phys, 37: 393-398.
29. SHRIEVE DC, ALEXANDER E, III, WEN PY et al. (1995). Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. Neurosurgery, 36: 275-282.
30. SIMON JM, CORNU P, BOISSERIE G et al. (2002). Brachytherapy of glioblastoma recurring in previously irradiated territory: predictive value of tumor volume. Int J Radiat Oncol Biol Phys, 53: 67-74.
31. SNEED PK, GUTIN PH, LARSON DA et al. (1994). Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost. Int J Radiat Oncol Biol Phys, 29: 719-727.
32. STEWART LA. (2002). Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet, 359: 1011-1018.
33. VENINGA T, LANGENDIJK HA, SLOTMAN BJ et al. (2001). Reirradiation of primary brain tumours: survival, clinical response and prognostic factors. Radiother Oncol, 59: 127-137.
34. WALLNER KE, GALICICH JH, KROL G, et al. (1989). Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys, 16: 1405-1409.